Logo

Vizgen: Terry Lo, Peidong Wang

Sep 14, 2020

Spatial gene expression analysis startup Vizgen has appointed Terry Lo as president and CEO, effective immediately. He has more than two decades of experience in developing commercialization strategies for life sciences companies, Vizgen said. Lo comes to Vizgen from Akoya Biosciences, where he was president. He has also held executive positions at PerkinElmer, Roche, Hologic, and Bristol-Myers Squibb. Lo has an MBA from the University of Chicago and a masters' degree in microbiology from Virginia Tech.

Interim CEO Peidong Wang will remain at Vizgen as VP of engineering.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.